427,308 Shares in Kimberly-Clark Corporation $KMB Purchased by Associated Banc Corp

Key Points

• Associated Banc Corp initiated a sizable Kimberly-Clark position, buying 427,308 shares worth about $41.6 million. The stake represents roughly 0.13% of Kimberly-Clark and 1% of the fund’s portfolio.
• Kimberly-Clark has completed its acquisition of Kenvue, adding a large consumer-health portfolio and targeting $2.1 billion in annual run-rate synergies. Investors will be watching integration and debt financing, as the deal’s enterprise value was nearly $49 billion.
• The company’s latest reported quarter missed analyst expectations for earnings and revenue, while analysts flagged consumer spending and cost pressures as potential headwinds. The stock carried a consensus “Hold” rating and an average target price of $110.67.

Associated Banc Corp bought a new position in Kimberly-Clark Corporation (NASDAQ:KMB - Free Report) in the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund bought 427,308 shares of the company's stock, valued at approximately $41,633,000. Kimberly-Clark makes up about 1.0% of Associated Banc Corp's portfolio, making the stock its 23rd largest holding. Associated Banc Corp owned 0.13% of Kimberly-Clark as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in the business. Mystic Asset Management Inc. raised its holdings in Kimberly-Clark by 0.5% during the third quarter. Mystic Asset Management Inc. now owns 20,354 shares of the company's stock valued at $1,983,000 after buying an additional 109 shares in the last quarter. Assetmark Inc. raised its stake in shares of Kimberly-Clark by 0.6% in the 1st quarter. Assetmark Inc. now owns 20,216 shares of the company's stock valued at $1,950,000 after acquiring an additional 121 shares in the last quarter. Annex Advisory Services LLC raised its stake in shares of Kimberly-Clark by 2.0% in the 3rd quarter. Annex Advisory Services LLC now owns 6,533 shares of the company's stock valued at $637,000 after acquiring an additional 125 shares in the last quarter. Root Financial Partners LLC lifted its holdings in Kimberly-Clark by 17.6% in the 1st quarter. Root Financial Partners LLC now owns 847 shares of the company's stock worth $82,000 after purchasing an additional 127 shares during the last quarter. Finally, Modera Wealth Management LLC lifted its holdings in Kimberly-Clark by 3.9% in the 3rd quarter. Modera Wealth Management LLC now owns 3,414 shares of the company's stock worth $333,000 after purchasing an additional 129 shares during the last quarter. 76.29% of the stock is owned by institutional investors.

Trending Headlines about Kimberly-Clark

Here are the key news stories impacting Kimberly-Clark this week:

• Positive Sentiment: Kimberly-Clark completed its acquisition of Kenvue, adding a broad consumer-health portfolio that includes 10 billion-dollar brands. The company reiterated expected annual run-rate synergies of $2.1 billion, offering potential for longer-term growth and cost savings. Read More.
• Neutral Sentiment: The acquisition is now closed, shifting investor focus from deal completion to integration, synergy delivery, and the combined company’s financial performance. KMB’s Q3 results are due November 5. Read More.
• Negative Sentiment: The transaction is substantial: its enterprise value was reported at nearly $49 billion. Kimberly-Clark also announced exchange offers involving up to $7 billion of new company notes, raising investor focus on financing and the added debt burden as it integrates Kenvue. Read More. Read More.
• Negative Sentiment: Analyst previews warn that weak consumer spending and rising costs could weigh on Q3 results, although product innovation and efficiency gains may provide some support. That uncertainty may limit enthusiasm ahead of the earnings report. Read More.

Kimberly-Clark Trading Down 3.5%

Shares of KMB stock opened at $104.46 on Wednesday. Kimberly-Clark Corporation has a 1 year low of $92.42 and a 1 year high of $116.82. The firm's fifty day simple moving average is $102.66 and its 200 day simple moving average is $103.09. The firm has a market capitalization of $34.74 billion, a P/E ratio of 14.53, a price-to-earnings-growth ratio of 5.85 and a beta of 0.25. The company has a current ratio of 0.91, a quick ratio of 0.69 and a debt-to-equity ratio of 3.45.

Kimberly-Clark (NASDAQ:KMB - Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $1.80 earnings per share for the quarter, missing analysts' consensus estimates of $2.01 by ($0.21). Kimberly-Clark had a net margin of 11.79% and a return on equity of 143.92%. The company had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $4.22 billion. During the same period last year, the company earned $1.92 earnings per share. Kimberly-Clark's revenue for the quarter was up .6% on a year-over-year basis. As a group, sell-side analysts predict that Kimberly-Clark Corporation will post 6.83 EPS for the current year.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the company. UBS Group upped their target price on Kimberly-Clark from $106.00 to $113.00 and gave the stock a "neutral" rating in a research report on Wednesday, October 28th. Wells Fargo & Company reduced their price objective on shares of Kimberly-Clark from $105.00 to $100.00 and set an "equal weight" rating for the company in a research note on Monday, October 5th. Freedom Capital upgraded shares of Kimberly-Clark from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, August 4th. Rothschild & Co Redburn dropped their target price on shares of Kimberly-Clark from $138.00 to $129.00 and set a "buy" rating on the stock in a report on Friday, October 9th. Finally, Barclays cut their target price on shares of Kimberly-Clark from $115.00 to $105.00 and set an "equal weight" rating for the company in a research report on Monday, September 14th. One equities research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $110.67.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation NASDAQ: KMB is a global consumer products company that develops and markets personal care, tissue and professional hygiene products. Its portfolio includes products for babies and children, feminine care, adult care, family care and workplace hygiene.

The company's well-known brands include Huggies diapers and wipes, Kleenex facial tissue, Cottonelle bathroom tissue, Scott toilet paper and paper towels, Kotex feminine care products, and Depend, Poise and GoodNites products.

Want to see what other hedge funds are holding KMB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Kimberly-Clark Corporation (NASDAQ:KMB - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.